Scientists have achieved another breakthrough in identifying ‘longevity genes’ – genes that allow the lucky bearers to live to 100 or more, even if their lifestyles aren’t particularly healthy.
Rather than one gene being responsible for longevity, the Dutch researchers claim to have discovered that a rare combination of genes is needed to live to such long ages. The discovery of genetic underpinnings of long life is exciting because scientists hope to be able to mimic the effects of the genes in the body with the world’s first anti-aging drugs – enabling the vast majority of the population without the fortuitious genetic makeup to share the long life expectancies of those who do.
It is hoped the findings will enable scientists to invent an anti-ageing drug which will slow the ageing process down considerably. If it came about, it would be the ultimate blockbuster for the pharmaceutical industry as delaying the signs and symptoms of old age have long been a worldwide craze and one that people spend billions of pounds on every year.
Dr David Gems, a longevity researcher at University College London, believes that these treatments will become widespread.
‘If we know which genes control longevity then we can find out what proteins they make and then target them with drugs. That makes it possible to slow down ageing,’ he said.
‘We need to reclassify it as a disease rather than a natural, benign process. Much of the pain and suffering in the world are caused by aging. If we can find a way to reduce that, then we are morally obliged to take it.’
